[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"chronic-glomerular-disease\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:chronic-glomerular-disease":38},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":4},"100569229",false,"NCT06691529","Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular Disease","The Association of Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular Disease","Inclusion Criteria:\n\n* All CKD patient aging between (18-70) years with known tubule-glomerular diseases.\n* At any eGFR.\n* All CKD patient have either type I\u002FII DM associated with CKD .\n\nExclusion Criteria:\n\n* CKD patients of Unknown etiology.\n* CKD patients with liver cirrhosis.\n* CKD patients secondry to documented diabetic nephropathy.\n* Patients with previous\u002Fcurrent HBV or HCV.\n* Pregnant CKD patients.\n* Patient commencing any hepatotoxic medication.","ALL","18 Years","70 Years",{"count":19,"type":20},500,"ESTIMATED","OBSERVATIONAL","The association of metabolic associated fatty liver disease in patients with chronic glomerular disease",[24,25],"Fatty Liver Disease","Chronic Glomerular Disease","NOT_YET_RECRUITING","2024-11-15",{"date":29,"type":30},"2024-11-18","ACTUAL",{"date":32,"type":20},"2024-12",{"date":34,"type":20},"2026-03",{"name":36,"class":37},"Assiut University","OTHER",""]